Russell Investments »

Context Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.1k 7.5k 0.55

More positions owned by Russell Investments

Nvidia Corp Common stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Common Stock (GOOG)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Micron Technology Common Stock (MU)
Taiwan Semiconductor Manufacturing Company Common Stock (TSM)
Meta Platforms Common Stock (META)
Mastercard Incorporated Common Stock (MA)
Advanced Micro Devices Common Stock (AMD)
Eli Lilly And Company Common Stock (LLY)
Tesla Common Stock (TSLA)
Applied Materials Common Stock (AMAT)

View all positions for Russell Investments

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics